Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 6/20 | 0.51 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.51 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.51 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4011486 | 0.88 | CHRNB2 (0.54) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4008526 | 0.85 | CHRNB2 (0.59) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4299154 | 0.85 | CHRNB4 (0.48) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4009219 | 0.84 | CHRNB2 (0.50) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4012345 | 0.84 | CHRNB2 (0.50) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4003627 | 0.83 | CHRNB4 (0.73) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4007434 | 0.83 | CHRNB4 (0.73) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4007296 | 0.82 | CHRNB2 (0.55) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4013037 | 0.82 | CHRNB2 (0.55) | CHRNB4CHRNA3CHRNB2CHRNA4 | |
| SCHEMBL4005927 | 0.81 | CHRNB2 (0.53) | CHRNB4CHRNA3CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009081246-A2 | BICYCLIC DIAMINES AS NICOTINIC RECEPTOR AGONISTS | PFIZER INC. (US) | 2009-07-02 | — | — | WO | claimed |
| WO-2009081246-A2 | BICYCLIC DIAMINES AS NICOTINIC RECEPTOR AGONISTS | PFIZER INC. (US) | 2009-07-02 | — | — | WO | disclosed |